| scholarly article | Q13442814 |
| P2093 | author name string | Ting Li | |
| Yan Lin | |||
| Lin Chen | |||
| Yunlong Wang | |||
| Chunhong Li | |||
| Na Hao | |||
| Zhongbing Liu | |||
| Zhirong Zhong | |||
| Jiayao Lyu | |||
| Meiling Zhou | |||
| P2860 | cites work | Pyrene absorption can be a convenient method for probing critical micellar concentration (cmc) and indexing micellar polarity | Q46660282 |
| The protective effects of curculigoside A on adjuvant-induced arthritis by inhibiting NF-кB/NLRP3 activation in rats | Q47356611 | ||
| Optimization of madecassoside liposomes using response surface methodology and evaluation of its stability | Q50453220 | ||
| Targeted delivery of low-dose dexamethasone using PCL-PEG micelles for effective treatment of rheumatoid arthritis. | Q53127053 | ||
| The sphingosine-1-phosphate derivative NHOBTD inhibits angiogenesis both in vitro and in vivo. | Q53407872 | ||
| Polylactide-Cholesterol Stereocomplex Micelle Encapsulating Chemotherapeutic Agent for Improved Antitumor Efficacy and Safety | Q57279695 | ||
| Role of tumor necrosis factor-α and platelet-activating factor in neoangiogenesis induced by synovial fluids of patients with rheumatoid arthritis | Q58831756 | ||
| Rheumatoid arthritis: treat now, not later! | Q71086317 | ||
| [Effectiveness and safety of biological therapy with adalimumab] | Q84105468 | ||
| Combination cytokine blockade: the way forward in therapy for rheumatoid arthritis? | Q85744181 | ||
| Interleukin-34 Aggravates the Severity of Arthritis in Collagen-Induced Arthritis Mice by Inducing Interleukin-17 Production | Q88385815 | ||
| Development of a macromolecular prodrug for the treatment of inflammatory arthritis: mechanisms involved in arthrotropism and sustained therapeutic efficacy | Q22000845 | ||
| Hypoxia-Inducible Factor (HIF) as a Target for Novel Therapies in Rheumatoid Arthritis | Q26738338 | ||
| Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3 | Q26771417 | ||
| Development of macromolecular prodrug for rheumatoid arthritis | Q27693332 | ||
| Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles: formulation, optimization and in vitro characterization | Q33437962 | ||
| Systematic review on the safety of methotrexate in rheumatoid arthritis regarding the reproductive system (fertility, pregnancy, and breastfeeding). | Q33505875 | ||
| Characterization and quantification of angiogenesis in rheumatoid arthritis in a mouse model using μCT. | Q34582128 | ||
| Direct chemotherapeutic dual drug delivery through intra-articular injection for synergistic enhancement of rheumatoid arthritis treatment | Q36109604 | ||
| The Evaluation of the Therapeutic Efficacy and Side Effects of a Macromolecular Dexamethasone Prodrug in the Collagen-Induced Arthritis Mouse Model | Q36403152 | ||
| The Histone Methyltransferase EZH2 Mediates Tumor Progression on the Chick Chorioallantoic Membrane Assay, a Novel Model of Head and Neck Squamous Cell Carcinoma | Q36865026 | ||
| Nimesulide is a selective COX-2 inhibitory, atypical non-steroidal anti-inflammatory drug | Q37107297 | ||
| Principles of nanoparticle design for overcoming biological barriers to drug delivery | Q37162182 | ||
| Atacicept, a novel B cell-targeting biological therapy for the treatment of rheumatoid arthritis. | Q37517575 | ||
| Anti-TNFalpha blockers, autoantibodies and autoimmune diseases | Q37524820 | ||
| Scavenger Receptor-Mediated Targeted Treatment of Collagen-Induced Arthritis by Dextran Sulfate-Methotrexate Prodrug | Q37541839 | ||
| Nanomedicines for inflammatory arthritis: head-to-head comparison of glucocorticoid-containing polymers, micelles, and liposomes | Q37627094 | ||
| Going with the flow: harnessing the power of the vasculature for targeted therapy in rheumatoid arthritis | Q38622301 | ||
| Preclinical Rheumatoid Arthritis: Progress Toward Prevention | Q38712937 | ||
| Targeted sustained delivery of antineoplastic agent with multicomponent polylactide stereocomplex micelle | Q38722444 | ||
| Understanding the role of cytokines in the pathogenesis of rheumatoid arthritis | Q38736239 | ||
| Folate Receptor-Targeted Dendrimer-Methotrexate Conjugate for Inflammatory Arthritis. | Q38842064 | ||
| Nanotherapeutics relieve rheumatoid arthritis | Q39160341 | ||
| Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug | Q39653805 | ||
| Mixed pH-sensitive polymeric micelles for combination drug delivery | Q39668739 | ||
| RGD-modified polymeric micelles as potential carriers for targeted delivery to integrin-overexpressing tumor vasculature and tumor cells | Q39837845 | ||
| Nimesulide improves the disease modifying anti-rheumatic profile of methotrexate in mice with collagen-induced arthritis. | Q42965764 | ||
| High intensity focused ultrasound-responsive release behavior of PLA-b-PEG copolymer micelles. | Q45970903 | ||
| The anti-angiogenic effects of 1-furan-2-yl-3-pyridin-2-yl-propenone are mediated through the suppression of both VEGF production and VEGF-induced signaling | Q46207244 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nimesulide | Q20994 |
| rheumatoid arthritis | Q187255 | ||
| methotrexate | Q422232 | ||
| RGD [plasma membrane] | Q50254263 | ||
| P304 | page(s) | 708-720 | |
| P577 | publication date | 2019-01-01 | |
| P1433 | published in | Theranostics | Q21051383 |
| P1476 | title | Enhanced Therapeutic Effect of RGD-Modified Polymeric Micelles Loaded With Low-Dose Methotrexate and Nimesulide on Rheumatoid Arthritis | |
| P478 | volume | 9 |
| Q92423981 | ASIC1a induces synovial inflammation via the Ca2+/NFATc3/ RANTES pathway |
| Q91828114 | Co-Delivery of Prednisolone and Curcumin in Human Serum Albumin Nanoparticles for Effective Treatment of Rheumatoid Arthritis |
| Q89621507 | Receptor targeting drug delivery strategies and prospects in the treatment of rheumatoid arthritis |
Search more.